Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-18-025074
Filing Date
2018-08-14
Accepted
2018-08-14 12:12:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 33269
  Complete submission text file 0000000000-18-025074.txt   46491
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filed for) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations